---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-015314"
form_type: "8-K"
ticker: "ZBIO"
cik: "0001953926"
company_name: "Zenas BioPharma, Inc."
filed_at: "2026-02-13T23:59:59+00:00"
generated_at: "2026-05-16T02:50:35.393531+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Zenas BioPharma adopts amended Short-Term Incentive Plan for annual cash bonuses

## Summary
- Plan effective Jan 1, 2026; provides discretionary annual cash bonuses based on company and individual performance.
- Target awards expressed as percentage of base salary; payouts capped at 150% of target.
- Employees hired after Sep 30 generally ineligible; must be employed through payment date.
- Administered by Board for executives and by CEO/leadership for other employees.
- Company retains right to amend or discontinue plan at any time.

## SEC filing metadata
- accession: 0001104659-26-015314
- form_type: 8-K
- ticker: ZBIO
- cik: 0001953926
- company_name: Zenas BioPharma, Inc.
- filed_at: 2026-02-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1953926/000110465926015314/0001104659-26-015314-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1953926/000110465926015314/tm266357d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-015314
- JSON: https://secwatch.observer/filing/0001104659-26-015314.json
- Plain text: https://secwatch.observer/filing/0001104659-26-015314.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.